Multivisceral resections in pancreatic cancer: identification of risk factors.

  • Christoph Burdelski
  • Matthias Reeh
  • Dean Bogoevski
  • Florian Gebauer
  • Michael Tachezy
  • Yogesh Vashist
  • Güllü Cataldegirmen
  • Emre F. Yekebas
  • Jakob R. Izbicki
  • Maximilian Bockhorn

Abstract

There is an assumption that multivisceral resections (MVRs) in patients with a pancreatic malignancy are associated with higher morbidity. The oncologic benefit, however, remains controversial.

Bibliographical data

Original languageEnglish
Article number12
ISSN0364-2313
DOIs
Publication statusPublished - 01.12.2011